近日，全球制药巨头辉瑞（Pfizer）接连宣布两项重要人事任命，进一步强化其在药物研发与临床开发领域的领导力。前美国FDA药品评价与研究中心（CDER）主任Patrizia Cavazzoni博士回归辉瑞，担任首席医学官（Chief Medical ...

近日，全球制药巨头辉瑞（Pfizer）接连宣布两项重要人事任命，进一步强化其在药物研发与临床开发领域的领导力。前美国FDA药品评价与研究中心（CDER）主任Patrizia Cavazzoni博士回归辉瑞，担任首席医学官（Chief Medical ...

US pharma giant Pfizer (NYSE: PFE) today announced that James List, has joined the company as chief internal medicine officer ...

The weight-loss drug market is evolving at a rapid speed, with leading pharma companies including Novo Nordisk (NVO) and Eli Lilly (NYSE:LLY) diving into the opportunity to make effective and targeted ...

Pfizer Supercharges Obesity Battle with Top J&J Exec ...

The Swiss pharma will base cardiometabolic drug research at the new Allston site. Elsewhere, AskBio advanced a gene therapy ...

Pfizer (PFE) stock gains as company appoints James List, a former J&J (JNJ) executive as Chief Internal Medicine Officer to ...

Shortly after bringing in a former FDA official to serve as its chief medical officer, Pfizer’s latest leadership appointment ...

Pfizer on Thursday named James List as the head of the drugmaker's Internal Medicine portfolio, where he will oversee the ...

Felix sat down with Imperial graduate and life sciences consultant Sayak Bhattacharya to discuss the state of the ...

In a report released today, Kerry Holford from Berenberg Bank maintained a Hold rating on Pfizer (PFE – Research Report), with a price target ...

There are lots of good dividend stocks to consider stepping into here, but only a few truly great income-producing prospects.